scholarly journals EPIDEMIOLOGICAL CHARACTERISTICS OF DRUG USE AND EFFECTIVENESS OF METHADONE SUBSTITUTION THERAPY IN HIV-POSITIVE INJECTING DRUG USERS INFECTED WITH VIRAL HEPATITIS C IN MINSK

2020 ◽  
Vol 4 (1) ◽  
pp. 81-85
Author(s):  
M. A. Shylava ◽  
◽  
A. V. Abramovich ◽  
I. N. Valchuk ◽  
M. L. Dotsenko ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Drug Use ◽  
Viral Hepatitis ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Hiv Positive ◽  
Substitution Therapy ◽  
Viral Hepatitis C ◽  
Epidemiological Characteristics

Viral hepatitis C infection among injecting drug users and their partners in Manipur

2021 ◽  
Vol 2 (1) ◽  
pp. 9
Author(s):  
RomeoSingh Karam ◽  
ThangjamDhabali Singh ◽  
BrogenSingh Akoijam ◽  
Nalinikanta Rajkumar
Keyword(s):  
Hepatitis C ◽  
Viral Hepatitis ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Hepatitis C Infection ◽  
Viral Hepatitis C

Recognition of Hepatitis C Virus Coinfection in HIV-Positive Injecting Drug Users in Asia

2007 ◽  
Vol 45 (3) ◽  
pp. 363-365 ◽  
Author(s):  
Nick Walsh ◽  
Peter Higgs ◽  
Nick Crofts
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Hiv Positive

scholarly journals Experience in the Treatment of Chronic Viral Hepatitis C in Children Born to HIV-positive Women

2015 ◽  
Vol 14 (4) ◽  
pp. 45-49
Author(s):  
V. N. Timchenko ◽  
Yu. A. Arkhipova ◽  
O. V. Bulina
Keyword(s):  
Hepatitis C ◽  
Viral Hepatitis ◽  
Chronic Viral Hepatitis ◽  
Hiv Positive ◽  
Hiv Positive Women ◽  
Viral Hepatitis C ◽  
Chronic Viral Hepatitis C

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

Addiction ◽  
2011 ◽  
Vol 106 (11) ◽  
pp. 1978-1988 ◽  
Author(s):  
Katy M. E. Turner ◽  
Sharon Hutchinson ◽  
Peter Vickerman ◽  
Vivian Hope ◽  
Noel Craine ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Substitution Therapy ◽  
Opiate Substitution Therapy ◽  
The Impact

Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia

2005 ◽  
Vol 16 (11) ◽  
pp. 749-754 ◽  
Author(s):  
Tim Rhodes ◽  
Lucy Platt ◽  
Ali Judd ◽  
Larissa Albertovna Mikhailova ◽  
Anya Sarang ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Hcv Infection ◽  
Hiv Positive ◽  
Sample Collection ◽  
Cross Sectional Survey ◽  
Almost All ◽  
Anti Hiv

The objective of this study was to estimate the prevalence of hepatitis C virus (HCV) infection and co-infection with HIV among injecting drug users (IDUs) in Togliatti City, Russia. Unlinked anonymous cross-sectional survey of IDUs recruited from community settings, with oral fluid sample collection for HCV and HIV antibody (anti-HCV, anti-HIV) testing, was carried out. The anti-HCV prevalence was 87% (357/411), anti-HIV prevalence 56% (234/418), and 93% (214/230) of HIV-positive IDUs were co-infected with HCV. Only 23% (94/411) of those HCV positive self-reported as such. In an adjusted model, increased odds of HCV positivity were associated with needle and syringe, as well as injecting paraphernalia sharing in the last four weeks. IDUs injecting more than once with the same needle also had raised odds. There were no marked associations between HCV positivity and the duration of injecting or age group. Almost all IDUs were HCV positive, and almost all HIV-positive IDUs were HCV co-infected. There is an urgent need to maximize syringe distribution coverage, develop health promotion targeting HCV prevention for IDUs, and improve access among IDUs to treatments for HIV and HCV infection.

Effects of age, gender, duration of drug use and infection with viral hepatitis B and C on lymphocyte subsets in a population of HIV-negative injecting drug users in Italy

1997 ◽  
Vol 2 (2) ◽  
pp. 201-206 ◽  
Author(s):  
GIOVANNI REZZA ◽  
PIETRO D'EGIDIO ◽  
ALESSANDRO COZZI LEPRI ◽  
DAMIANO COSTANTINI ◽  
ANDREA PETRUCCI ◽  
...  
Keyword(s):  
Drug Use ◽  
Hepatitis B ◽  
Viral Hepatitis ◽  
Drug Users ◽  
Lymphocyte Subsets ◽  
Injecting Drug Users ◽  
Viral Hepatitis B ◽  
Hiv Negative

scholarly journals Hepatitis C virus genotypes in injecting drug users from Romania

Open Medicine ◽  
2011 ◽  
Vol 6 (5) ◽  
pp. 672-678 ◽  
Author(s):  
Camelia Sultana ◽  
Codruta Vagu ◽  
Aura Temereanca ◽  
Camelia Grancea ◽  
Josefina Slobozeanu ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Drug Use ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Hiv Antibodies ◽  
Virus Genotypes ◽  
Hcv Transmission ◽  
History Of ◽  
Hepatitis C Virus Genotypes

AbstractDue to the increasing number of infections related to injecting drug use, both the pattern of hepatitis C virus (HCV) transmission, and the circulating genotypes in Europe have changed. As there are little available data in this respect for Romania, the aim of our study was a preliminary analysis of the distribution of HCV genotypes circulating among injecting drug users (IDUs). Of the 45 IDUs evaluated (86.7% men, mean age − 27.6 ± 3.7 years, mean age at first drug use − 17.5 ± 3.9 years), 88.9% presented anti-HCV antibodies, with higher rates in those with an injecting history of more than 10 years; 57.8% of the subjects had detectable HCV viral load. Only 6.7% had markers of chronic hepatitis B infection, and none had anti-HIV antibodies. While HCV subtype 1b is still prevalent (in 50% of the viraemic subjects), other subtypes begin to emerge, especially in younger patients (1a — in 23.1%, 4 — in 11.5%, 3a — in 7.7% of the cases). These data indicate the possibility of major shifts in the distribution of the dominant subtype, underlining the need for close surveillance of HCV infections in IDUs, who can act as a bridging group toward the general population.

Clinical and epidemiological characteristics of acute viral hepatitis C in the Yaroslavl region

2021 ◽  
pp. 8-13
Author(s):  
Maksim Sergeevich Bokhonov ◽  
Larisa Evgenevna Galitsina
Keyword(s):  
Hepatitis C ◽  
Viral Hepatitis ◽  
Acute Viral Hepatitis ◽  
Epidemiological Features ◽  
Viral Hepatitis C ◽  
Epidemiological Characteristics

Clinical and epidemiological features of acute viral hepatitis C were studied. It was revealed that the disease more often occurs in the jaundice form of medium degree and severity. In the pre-jaundice period, flu-like syndrome was more common, and arthralgic syndrome was less common. It was found that in 40% of cases, an epidemiologically significant event that led to infection is detected in the anamnesis. People aged 30 to 49 are more likely to get sick. 40% of patients have various comorbidities.

scholarly journals The Australian Study of HIV and Injecting Drug Use. Part I: Prevalence for HIV, hepatitis B and hepatitis C among injecting drug users in four Australian cities

1997 ◽  
Vol 16 (3) ◽  
pp. 207-214 ◽  
Author(s):  
WENDY M. LOXLEY ◽  
MIKE PHILLIPS ◽  
SUSAN J. CARRUTHERS ◽  
JUDE S. BEVAN
Keyword(s):  
Hepatitis C ◽  
Drug Use ◽  
Hepatitis B ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Injecting Drug Use ◽  
Australian Study
Sign in / Sign up

Export Citation Format

Share Document